ASND
Ascendis Pharma A/S
NASDAQ · Healthcare · Biotechnology · DK
$265.71
+2.48%Forward multiples
Based on analyst estimates
- P/E forward
- 33.15x
- P/E 2026E
- 16.15x
- P/E 2027E
- 25.76x
- P/E 2028E
- 16.68x
- P/S forward
- 8.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.66x
- PEG TTM
- —
- Price / book
- 10.90x
- Price / sales
- 14.85x
- Price / cash flow
- 44.57x
Enterprise value
- Enterprise value
- $17.1B
- EV / sales
- 14.51x
- EV / EBITDA
- 195.78x
- EV / EBIT
- 139.75x
- Market cap
- $17.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026